Adaptin Bio, Inc. (APTN)

Adaptin Bio Statistics

Total Valuation

Adaptin Bio has a market cap or net worth of 53.11 million. The enterprise value is 53.05 million.

Market Cap	53.11M
Enterprise Value	53.05M

Important Dates

The last earnings date was Thursday, May 28, 2026.

Earnings Date	May 28, 2026
Ex-Dividend Date	n/a

Share Statistics

Adaptin Bio has 8.85 million shares outstanding. The number of shares has increased by 119.07% in one year.

Current Share Class	8.85M
Shares Outstanding	8.85M
Shares Change (YoY)	+119.07%
Shares Change (QoQ)	+2.58%
Owned by Insiders (%)	34.89%
Owned by Institutions (%)	n/a
Float	2.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-29.91
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-9.29
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.28

Current Ratio	0.28
Quick Ratio	0.12
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2,938.05

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-200.44%
Return on Invested Capital (ROIC)	-3,391.70%
Return on Capital Employed (ROCE)	321.51%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-1.43M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	306

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-5.71M
Pretax Income	-5.71M
Net Income	-5.71M
EBITDA	n/a
EBIT	-5.71M
Earnings Per Share (EPS)	-0.67

Balance Sheet

The company has 301,309 in cash and 240,698 in debt, with a net cash position of 60,611 or 0.01 per share.

Cash & Cash Equivalents	301,309
Total Debt	240,698
Net Cash	60,611
Net Cash Per Share	0.01
Equity (Book Value)	-1.78M
Book Value Per Share	-0.20
Working Capital	-1.78M

Cash Flow

Operating Cash Flow	-3.09M
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	-92,407
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Adaptin Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-119.07%
Shareholder Yield	-119.07%
Earnings Yield	-10.75%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1